SEC Form 4 · accession 0001628280-26-051811
Strata Critical Medical, Inc. · SRTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Melissa M. Tomkiel
Officer — Co-CEO and General Counsel · Director
Period of report
Jul 30, 2026
Accepted (ET)
Aug 3, 2026 · 4:06 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001779128
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A common stock, $0.0001 par value per shareF1 | Jul 30, 2026 | A | 208,929 | $0.00 | A | 2,101,703 | D | |
| Class A common stock, $0.0001 par value per shareF2 | Jul 30, 2026 | A | 206,953 | $0.00 | A | 2,308,656 | D | |
| Class A common stock, $0.0001 par value per shareF3 | Jul 31, 2026 | F | 212,309 | $5.09 | D | 2,096,347 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares that were acquired upon the certification of the Compensation Committee of the Issuer's Board of Directors of the satisfaction of performance criteria underlying an award of performance-based restricted stock units ("PSUs") granted to the Reporting Person on March 8, 2024.
- F2Represents shares that were acquired upon the certification of the Compensation Committee of the Issuer's Board of Directors of the satisfaction of performance criteria underlying an award of performance-based restricted stock units ("PSUs") granted to the Reporting Person on March 20, 2025.
- F3Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of PSUs.